Exam 1: Drug Delivery: An Evolving Concept
Exam 1: Drug Delivery: An Evolving Concept21 Questions
Exam 2: Barriers to Drug Delivery33 Questions
Exam 3: Routes of Drug Delivery29 Questions
Exam 4: Novel Drug Delivery Systems31 Questions
Exam 5: Controlled Drug Delivery31 Questions
Exam 6: Multifunctional Nanocarriers for Tumor Drug Delivery and Imaging37 Questions
Exam 7: Ocular Drug Delivery39 Questions
Exam 8: Transmucosal Drug Delivery23 Questions
Exam 9: Transdermal Drug Delivery21 Questions
Exam 10: Pulmonary and Nasal Drug Delivery47 Questions
Exam 11: Vaginal Drug Delivery19 Questions
Exam 12: Drug Delivery to the CNS: Breaking Down the Barrier57 Questions
Exam 13: Gene Delivery40 Questions
Exam 14: Peptide and Protein Drug Delivery40 Questions
Exam 15: Drug Metabolomics and Proteomics Analysis in Drug Delivery and Discovery55 Questions
Select questions type
Drug absorption is often limited by the presence of which of the following barriers?
Free
(Multiple Choice)
4.8/5
(41)
Correct Answer:
A,B,C
Bioavailability is an important pharmacodynamics parameter.
Free
(True/False)
4.7/5
(42)
Correct Answer:
False
Fill in the blank: The new molecules need to be tested for toxicities in both________ and________ dosing because toxicological concerns are key factors in determining the developability of a drug and are a major cause of attrition.
Free
(Short Answer)
4.8/5
(40)
Correct Answer:
acute,chronic
Toxicological studies for a new molecule are only required for acute dosing.
(True/False)
4.9/5
(31)
Fill in the blank: No drug can be commercially viable if it does not meet the criteria for optimum ____________,good safety profile (sufficient therapeutic window),and minimal_______________.
(Short Answer)
4.9/5
(39)
An in vivo model should have all the biochemical,cellular,and physiological complexities of human systems to successfully predict the actual efficacy of the drug candidate.
(True/False)
4.8/5
(39)
Match the Factors affecting drug development
The lead molecule being developed should have optimum absorption,distribution,metabolism,and excretion in humans.
(Multiple Choice)
4.8/5
(37)
Bioavailability,volume of distribution and elimination half-life are important__________ parameters.
(Multiple Choice)
4.8/5
(34)
As long as the active drug is safe toxicological studies for its metabolites are not required.
(True/False)
4.8/5
(35)
The setting of druggability and developability criteria depends on factors such as commercialization and scientific feasibility.
(True/False)
4.8/5
(35)
The crystalline state,salt form,and the presence of formulation excipients do not have any bearing on the overall stability of a drug.
(True/False)
4.7/5
(37)
In the initial stages of drug discovery,new bioactive molecules are generally identified by
(Multiple Choice)
4.9/5
(37)
Total body clearance is the rate at which the systemic circulation eliminates the active drug.
(True/False)
4.8/5
(32)
__________ dosing is the most common and convenient way to administer most drugs.
(Short Answer)
4.8/5
(28)
A drug needs to be commercially viable even if it does not meet the criteria for optimum therapeutic efficacy,good safety profile (sufficient therapeutic window),and minimal adverse effects.
(True/False)
5.0/5
(30)
Match the Factors affecting drug development
The new molecules need to be safe in both acute and chronic dosing.
(Multiple Choice)
5.0/5
(42)
For most drugs (unless they are rapidly acting) low to moderate clearance is preferred.
(True/False)
4.9/5
(42)
Fill in the blank: Often,the drug is required only at the physiological___________,and hence extensive biodistribution may cause ___________and unwanted side effects.
(Short Answer)
4.9/5
(44)
Match the Factors affecting drug development
The lead molecule being developed should have optimum stability,solubility and minimum interaction with excipients.
(Multiple Choice)
4.7/5
(42)
Showing 1 - 20 of 21
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)